UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 6.

Ghadjar, P; Hyoz, S; Bernhard, J; Zwahlen, D; Holscher, T; Gut, P; Guckenberger, M; Hildebrandt, G; Muller, A; Plasswilm, J; Papachristofilou, A; Stalder, L; Biaggi-Rudolf, C; Sumila, M; Kranzbuhler, H; Najafi, Y; Ost, P; Azinwi, N; Reuter, C; Bodis, S; Kaouthar, K; Wust, P; Thalmann, G; Aebersold, D (2015). Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: first results of the randomized trial SAKK 09/10. Journal of Clinical Oncology, 33(35):4158-4166.

Ghadjar, P; Sun, H; Zimmermann, F; Bodis, S; Bernier, J; Studer, G; Aebersold, D M (2013). Physical examination during chemoradiation predicts outcome of locally advanced head and neck cancer. Secondary results of a randomized phase III trial (SAKK 10/94). Oral Oncology, 49(10):1006-1009.

Sassowsky, M; Gut, P; Hölscher, T; Hildebrandt, G; Müller, A C; Najafi, Y; Kohler, G; Kranzbühler, H; Guckenberger, M; Zwahlen, D R; Azinwi, N C; Plasswilm, L; Takacs, I; Reuter, C; Sumila, M; Manser, P; Ost, P; Böhmer, D; Pilop, C; Aebersold, D M; Ghadjar, P (2013). Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10. International Journal of Radiation Oncology, Biology, Physics, 87(3):534-541.

Ghadjar, P; Simcock, M; Studer, G; Allal, A; Ozsahin, M; Bernier, J; Töpfer, M; Zimmermann, F; Betz, M; Glanzmann, C; Aebersold, D (2012). Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94). International Journal of Radiation Oncology, Biology and Physics, 82(2):524-531.

Ghadjar, P; Simcock, M; Zimmermann, F; Betz, M; Bodis, S; Bernier, J; Studer, G; Aebersold, M (2012). Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94). Radiotherapy and Oncology, 104(2):213-218.

Ghadjar, P; Blank-Liss, W; Simcock, M; Hegyi, I; Beer, K T; Moch, H; Aebersold, D M; Zimmer, Y (2009). MET Y1253D-activating point mutation and development of distant metastasis in advanced head and neck cancers. Clinical and Experimental Metastasis, 26(7):809-815.

This list was generated on Tue Jul 25 10:48:03 2017 CEST.